|
⚲
|
| Keyboard |
| Kesten Steven
✚
|
|
|---|---|
| CIK # | 0001651191 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001651191] | |
| 4 | [0001651191] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Plus Therapeutics Inc | |
| Kesten Steven |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Plus Therapeutics Inc CYTX
Common Stock
|
2016-06-15 | Option exercise | 200 | ||
|
Plus Therapeutics Inc CYTX
Warrants (Right to Buy) · derivative
|
2016-06-15 | Option exercise | 100 | ||
|
Plus Therapeutics Inc CYTX
Subscription Rights (Right to Buy) · derivative
|
2016-06-15 | Option exercise | 200 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Common Stock
|
2016-01-28 | Grant | 47,000 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Employee Stock Option · derivative
|
2016-01-04 | Grant | 699,660 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Common Stock
|
2015-08-19 | Buy | 6,000 | $0.39 | 2,340 |